Excessive false-positive errors in single-arm phase II trials: A simulation-based analysis

被引：0

作者：

Tang, H. ^{[1
]}

Foster, N. R. ^{[1
]}

Grothey, A. ^{[1
]}

Ansell, S. M. ^{[1
]}

Sargent, D. J. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6512

引用

页数：2

共 50 条

[41] Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
Shi, Haolun
Yin, Guosheng
BIOMETRICS, 2018, 74 (03) : 1055 - 1064
[42] Trastuzumab combined with irinotecan in patients with HER2-positive metastatic colorectal cancer: A phase II multicenter single-arm study and exploratory biomarker analysis
Xu, Ting
Wang, Xicheng
Xin, Ying
Wang, Zhenghang
Wang, Yakun
Qi, Changsong
Liu, Dan
Li, Yanyan
Gong, Jifang
Li, Jian
Huang, Depei
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[43] Combined pyrotinib and fulvestrant for hormone receptor-positive and HER2-positive metastatic breast cancer: A multicenter, single-arm, phase II trial
Zhao, Jianli
Yu, Yunfang
Ren, Wei
Ding, Linxiaoxiao
Chen, Yongjian
Yuan, Peng
Yue, Jian
Yang, Yaping
Zou, Guorong
Chen, Tao
Chai, Jie
Zhang, Li
Wu, Wenjing
Zeng, Yinduo
Gui, Xiujuan
Cai, Yangyang
Luo, Simin
Yuan, Zhongyu
Zhang, Kang
Yao, Herui
Wang, Ying
MEDCOMM, 2025, 6 (01):
[44] A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases
Shah, Ami N.
Santa-Maria, Cesar A.
Mukhija, Dhruvika
Shah, Nikita
Kang, Anthony K.
Kumthekar, Priya
Burdett, Kirsten
Chandra, Shruti
Chang, Jenny
Tsarwhas, Dean
Woodman, Jill
Jovanovic, Borko
Gerratana, Lorenzo
Gradishar, William
Cristofanilli, Massimo
CLINICAL BREAST CANCER, 2023, 23 (03) : 324 - 329
[45] Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study
Liu, Jiaxuan
He, Maiyue
Jiang, Mingxia
Zhou, Shihan
Zhang, Mengqi
Li, Yiqun
Chen, Shanshan
Cai, Ruigang
Mo, Hongnan
Lan, Bo
Ma, Fei
Xu, Binghe
Li, Qiao
BMC CANCER, 2024, 24 (01)
[46] Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)
Hwang, E. Shelley
Hyslop, Terry
Hendrix, Laura H.
Duong, Stephanie
Bedrosian, Isabelle
Price, Elissa
Caudle, Abigail
Hieken, Tina
Guenther, Joseph
Hudis, Clifford A.
Winer, Eric
Lyss, Alan P.
Dickson-Witmer, Diana
Hoefer, Richard
Ollila, David W.
Hardman, Timothy
Marks, Jeffrey
Chen, Yunn-Yi
Krings, Gregor
Esserman, Laura
Hylton, Nola
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1284 - +
[47] Bayesian Predictive Probability Based on a Bivariate Index Vector for Single-Arm Phase II Study With Binary Efficacy and Safety Endpoints
Yoshimoto, Takuya
Shinoda, Satoru
Yamamoto, Kouji
Tahata, Kouji
PHARMACEUTICAL STATISTICS, 2025, 24 (01)
[48] A single-arm biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cell cancer (PRCC).
Choueiri, Toni K.
Plimack, Elizabeth R.
Arkenau, Hendrik-Tobias
Jonasch, Eric
Heng, Daniel Yick Chin
Powles, Thomas
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[49] Clinician-trialist rounds: 18. Should young (and old!) clinician-trialists perform single-arm Phase II futility trials?
Sackett, David L.
CLINICAL TRIALS, 2013, 10 (06) : 987 - 989
[50] Neoadjuvant niraparib monotherapy in homologous recombination deficiency-positive advanced ovarian cancer: a prospective, multicenter, single-arm, phase II study (NANT)
Li, Huayi
Liu, Dan
Zhang, Wei
Wang, Ping
Li, Jundong
Shan, Wanying
Liu, Ronghua
Chen, Gang
Wu, Mingfu
Li, Xiao
Liu, Cheng
Yin, Rutie
Zhou, Shengtao
Li, Maomao
He, Shanyang
Zhao, Guangnian
Song, Kun
Hong, Li
Ma, Ding
Gao, Qinglei
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A8 - A9

← 1 2 3 4 5 →